APA (7th ed.) Citation

TM, B., S, L., BJ, M., B, R., & MG, P. (2017). Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 64(9), 1283. https://doi.org/10.1093/cid/cix129

Chicago Style (17th ed.) Citation

TM, Block, Locarnini S, McMahon BJ, Rehermann B, and Peters MG. "Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 64, no. 9 (2017): 1283. https://doi.org/10.1093/cid/cix129.

MLA (9th ed.) Citation

TM, Block, et al. "Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 64, no. 9, 2017, p. 1283, https://doi.org/10.1093/cid/cix129.